Literature DB >> 12546840

New ways to treat bacterial infections.

Peter W Taylor1, Paul D Stapleton, J Paul Luzio.   

Abstract

There is an urgent need for fresh approaches to the treatment of bacterial infections because of the changing patterns of infectious disease and the emergence of bacterial strains resistant to current antibiotics. Modification of the cell phenotype to sensitize bacteria to components of the hosts' immune system or to previously ineffective antibiotics could prevent the emergence of the resistant genotype. In addition, the use of light-activated antibacterial agents and lytic bacteriophage specific for key pathogens should be considered as safe and inexpensive alternatives to conventional treatment regimens for certain non-systemic infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12546840     DOI: 10.1016/s1359-6446(02)02498-4

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  33 in total

Review 1.  Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules.

Authors:  Shyam Sundar; Vijay Kumar Prajapati
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Antimicrobial properties of green tea catechins.

Authors:  Peter W Taylor; Jeremy M T Hamilton-Miller; Paul D Stapleton
Journal:  Food Sci Technol Bull       Date:  2005

3.  7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia.

Authors:  Magally Romero-Tabarez; Rolf Jansen; Marita Sylla; Heinrich Lünsdorf; Susanne Häussler; Dwi A Santosa; Kenneth N Timmis; Gabriella Molinari
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Advances in antimicrobial photodynamic inactivation at the nanoscale.

Authors:  Nasim Kashef; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanophotonics       Date:  2017-08-01       Impact factor: 8.449

5.  Virulence of Pseudomonas aeruginosa cells surviving photodynamic treatment with toluidine blue.

Authors:  Mrinalini Sharma; Harsha Bansal; Pradeep Kumar Gupta
Journal:  Curr Microbiol       Date:  2005-04-11       Impact factor: 2.188

Review 6.  Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation?

Authors:  Nasim Kashef; Michael R Hamblin
Journal:  Drug Resist Updat       Date:  2017-07-26       Impact factor: 18.500

Review 7.  Recent advances in photodynamic therapy for cancer and infectious diseases.

Authors:  Xutong Shi; Can Yang Zhang; Jin Gao; Zhenjia Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-05-06

8.  Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1.

Authors:  Andrea Zelmer; Mark Bowen; Anne Jokilammi; Jukka Finne; J Paul Luzio; Peter W Taylor
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

9.  Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment.

Authors:  Anabela Tavares; Carla M B Carvalho; Maria A Faustino; Maria G P M S Neves; João P C Tomé; Augusto C Tomé; José A S Cavaleiro; Angela Cunha; Newton C M Gomes; Eliana Alves; Adelaide Almeida
Journal:  Mar Drugs       Date:  2010-01-20       Impact factor: 5.118

10.  Effect of ethanolic extract of Ecballium elaterium against Staphylococcus aureus and Candida albicans.

Authors:  Ghaleb Adwan; Yousef Salameh; Kamel Adwan
Journal:  Asian Pac J Trop Biomed       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.